Haeri, A. (2017). Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment. Iranian Journal of Pharmaceutical Research, 16(2), 411-412. doi: 10.22037/ijpr.2017.2110
MLA
Azadeh Haeri. "Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment". Iranian Journal of Pharmaceutical Research, 16, 2, 2017, 411-412. doi: 10.22037/ijpr.2017.2110
HARVARD
Haeri, A. (2017). 'Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment', Iranian Journal of Pharmaceutical Research, 16(2), pp. 411-412. doi: 10.22037/ijpr.2017.2110
VANCOUVER
Haeri, A. Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment. Iranian Journal of Pharmaceutical Research, 2017; 16(2): 411-412. doi: 10.22037/ijpr.2017.2110
)